History Ran bir Singh & Gur bax Singh, 1937 Distributor for a J apanese Co. “Shionogi” 1957, Bhai Mohan Singh bought the Company from his cousins 1998, entered to United States- Biggest market for R anbaxy
Cont … Daiichi Sankyo acquired a controlling share, 2008 In 2014, Sun Pharmaceutical Industries Limited acquired entire 63.4% share of Ranbaxy Export- 125 countries, ground operation in 43 & 21 manufacturing facilities in eight countries.
Problems faced by Ranbaxy In 2004-05, Dinesh Thakur & Rajinder Kumar blew the Whistle Received 1st warning letter from FDA, US 2 nd warning by FDA, restricted in import of drugs. Disallowing production of Lipitor by Pfizer
Cont … In 2012, stopped production drug called Atorvastating I n 2013, US fine imposed of US$ 500 million found guilty of misrepresenting clinical generic drug data selling adulterated drugs to the United States.
Cont … selling adulterated drugs to the United States. Found human hair in tablets Oil spot on tablets lack of running water facilities in toilet
Positive Aspects of Ranbaxy “ Ranbaxy is a good corporate which is following a traditional values and modern techniques simultaneously, which help them to reach top in Indian pharmaceutical market based on their sales volume .” Best Pharma Company for the year 2 011 by Dun & Bradstreet
Cont … Produce good quality with affordable drug Frost & Sullivan Malaysia Excellence Award for being adjudged the Malaysian Pharmaceutical Company of the Year in the Generics Drug Category